Contact Us
  • Choose License Type

Electrosurgical devices are used to perform coagulation, fulguration, desiccation, tissue ablation and cutting procedures. Electrosurgery is carried out by conversion of electromagnetic energy into kinetic energy inside the tissue of biological cell which is further converted to thermal energy providing desired effect.

The global electrosurgical devices market is estimated to account for US$ 6,087.3 Mn in terms of value in 2020 and is expected to reach US$ 9,677.6 Mn by the end of 2027.

Global Electrosurgical Devices Market: Drivers

Approval and launch of new devices is expected to propel growth of the global electrosurgical devices market over the forecast period. For instance, in May 2019, Olympus Corporation announced the launch and 510(k) clearance of the ESG-150 Electrosurgery Generator at Digestive Disease Week 2019.

Global Electrosurgical Devices Market: Opportunities

R&D in non-thermally operated electrosurgical devices is expected to offer lucrative growth opportunities for players in the global electrosurgical devices market. For instance, in April 2020, researchers from Eberhard-Karls-University Tübingen, Germany, reported that Martin Argon Plasma Beamer System is a suitable option for in vivo Martin Argon Plasma Beamer System treatment of precancerous lesions of the cervix and of cervical cancer.

Global Electrosurgical Devices Market: Restraints

Lack of skilled surgeons, especially in emerging economies, is expected to hinder growth of the global electrosurgical devices market.

Key Takeaways:

The global electrosurgical devices market was valued at US$ 5,698.4 Mn in 2019 and is forecast to reach a value of US$ 9,677.6 Mn by 2027 at a CAGR of 6.8% between 2020 and 2027. Major factor driving the growth of global electrosurgical devices market during the forecast period include technological advancement, and increasing number of surgeries.          

General Surgery held dominant position in the global electrosurgical devices market in 2019, accounting for 31.0% share in terms of value, followed by Gynaecology and Cardiology, respectively. Increasing prevalence of diseases such as cancer which require

Market Trends

Major players in the global electrosurgical devices market are focused on launching new products to expand their product portfolio. For instance, in June 2020, Olympus Corporation launched HookKnifeJ for the esophagus, stomach and colon and the TriangleTipKnifeJ for the esophagus and stomach.

Major players in the market are also focused on approval and launch of new products to expand their product portfolio. For instance, in November 2019, US Medical Innovations, LLC received the U.S. Food and Drug Administration’s 510(k) clearance to market and sell the Canady Plasma Smart XL-1000 Electrosurgical Generator (CPSXEG) with accessories.

Regulations

Japan (APAC)

In 2014, Japan’s PMD Act (Pharmaceuticals and Medical Devices Act) created a framework for regulation of medical devices and diagnostics. By 2018, the agency is going to set standard evaluation periods for all types of PMDA Components, including:

  • New Devices - 12 months for normal and 9 months for priority review
  • Improved - 7 months with clinical data and 9 months without
  • Generic Medical Devices - 5 months for new approvals and 4 months for partial changes

Global Electrosurgical Devices Market: Competitive Landscape   

Major players operating in the global electrosurgical devices market include, Bovie Medical Corporation, Medtronic Plc, BOWA-Electronic GmbH & Co. KG, KLS Martin, B. Braun Melsungen AG, Conmed, Olympus Corp., Boston Scientific Corporation, Erbe Elektromedizin GmbH, Symmetry Surgical Inc., Encision Inc., Gala Therapeutics, Inc., Apyx Medical Corporation, and Johnson & Johnson Services, Inc.

Global Electrosurgical Devices Market: Key Developments

Major players in the global electrosurgical devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2019, Aesculap, Inc. launched six new Caiman Maryland jaw vessel sealers at the 2019 AAGL Global Congress on Minimally Invasive Gynecology in Vancouver, BC.

Similarly, in September 2019, Gala Therapeutics, Inc. received the U.S. Food and Drug Administration’s Breakthrough Device Designation for the RheOxTM Bronchial RheoplastyTM system, a minimally invasive procedure to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients with chronic bronchitis.

Segmentation

  • By Product Type
    • Radiofrequency Electrosurgical Devices
      • Monopolar Devices
      • Bipolar Devices
    • Electrocautery Devices
      • Monopolar Devices
      • Bipolar Devices
    • Electrosurgical Accessories
  • By Application
    • General surgery
    • Gynecology
    • Cardiology
    • Urology
    • Dermatology & Cosmetology
    • Others
  • By End User
    • Hospitals
    • ASC’s
    • Specialized Clinics
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner